Industries > Pharma > Global Precision Medicine Market Forecast 2019-2029

Global Precision Medicine Market Forecast 2019-2029

Companion Diagnostics, Biomarker-based Test, Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics, Pharmaceuticals & Biotechnology Companies, Diagnostic Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Cancer, Cardiovascular Diseases, Central Nervous System, Infectious Diseases

PUBLISHED: 30 May 2019
PAGES: 212
PRODUCT CODE: PHA0424

Clear
WOOCS 2.2.1

The global precision medicine market is expected to grow at an estimated CAGR of 10.5% from 2018 to 2029. In the precision medicine market, the Diagnostic Tool companies’ segment is dominating the global market and accounted for $23.36 billion in 2018 due to the development of large number of diagnostic and genetic tests.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 212-page report you will receive 98 tables and 63 figures– all unavailable elsewhere.

The 212-page report provides clear detailed insight into the global precision medicine market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Precision Medicine Market forecasts from 2019-2029

• Along with revenue prediction for the overall market for the global precision medicine market, our investigation shows forecasts to 2029 for the market segmented by technology:
– Companion Diagnostics
– Biomarker-based Test
– Targeted Therapeutics
– Pharmacogenomics
– Molecular Diagnostics

The report discusses key trends, developments and participants.

• This report breaks down the precision medicine market forecast to 2029 by end-users:
– Pharmaceuticals & Biotechnology Companies
– Diagnostic Companies
– Healthcare IT/Big Data Companies
– Clinical Laboratories

The report discusses key trends, developments and participants.

• This report also breaks down the precision medicine market forecast to 2029 by therapeutic application:
– Cancer
– Cardiovascular Diseases
– Central Nervous System
– Infectious Diseases
– Immunology
– Others

The report discusses key trends, developments and participants.

• This study provides precision medicine market forecasts to 2029 for these regional markets:
– North America: US & Canada
– Europe: Germany, UK, France, Italy, Spain, Rest of Europe
– Asia-Pacific: China, japan, India, Australia, South Korea, Rest of Asia-Pacific
– Middle East & Africa: South Africa, Saudi Arabia, Rest of Middle East & Africa
– Latin America: Brazil, Mexico, Rest of Latin America

For each regional market, the report discusses key trends, developments and participants.

• This report profiles selected leading companies that are the main players in the global precision medicine market:
– Abbott
– Danaher Corporation
– GE Healthcare
– GlaxoSmithKline
– Illumina, Inc.
– Johnson & Johnson
– Laboratory Corporation of America Holdings
– Novartis
– Pfizer
– QIAGEN
– Thermo Fisher Scientific, Inc.

Global Precision Medicine Market Forecast 2019-2029

• Our study discusses the drivers, restraints as well as the opportunities in the global precision medicine market.

• This study also analyzed the global precision medicine market with Porter’s Five Forces Analysis as well as Value Chain Analysis

• This report discusses selected market developments in the precision medicine market: partnership, collaboration, join venture, acquisitions, product launch, product development, expansions, patents, approvals.

Visiongain’s study is intended for anyone requiring commercial analyses for the global precision medicine market. You find data, trends and predictions.

Buy our report today Global Precision Medicine Market Forecast 2019-2029: Companion Diagnostics, Biomarker-based Test, Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics, Pharmaceuticals & Biotechnology Companies, Diagnostic Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Cancer, Cardiovascular Diseases, Central Nervous System, Infectious Diseases.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Precision Medicine Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Precision Medicine Market Forecast 2019-2029


Latest Pharma news

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

READ

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

READ

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

READ

Visiongain Publishes Drug Discovery Outsourcing Market Report 2020-2030

The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.

07 September 2020

READ

Categories

Category